RecruitingNCT01905826

Natural History Study of GATA2 Deficiency and Related Disorders

The Natural History of GATA2 Deficiency and Related Disorders


Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment

600 participants

Start Date

Aug 26, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

Background: \- GATA2 deficiency is a genetic disorder that can cause problems with a person s immune system and other body systems. Some people who have this disorder develop few problems from it. Others can have a wide range of health problems, from skin problems, to hearing loss, to cancer. These problems can happen at any age. Researchers want to study GATA2 deficiency to better understand what types of health problems it can cause, and why it causes problems in some people but not others, and at different ages. Objectives: \- To improve understanding of GATA2 deficiency so there can be better diagnostic tests and treatments in the future. Eligibility: \- People 2 years of age or older who have a GATA2 gene mutation or certain health conditions that are commonly seen in people with this mutation and their blood relatives. Design: * Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected to see whether participants have the GATA2 genetic mutation. Several other tests may be recommended, but participants can decline to take them. * Participants will be eligible to receive standard care for GATA2 deficiency through this protocol. They may be eligible for other clinical trials at the National Institutes of Health as well. * Participants will have regular study visits once a year to evaluate their GATA2 deficiency. Participants will take part in the study for at least 3 years and up to 15 years. At these follow-up visits, participants will fill out a questionnaire and take a physical exam and blood tests. Other tests may be performed as needed.


Eligibility

Min Age: 2 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is following people who have a rare genetic condition called GATA2 deficiency — which affects the immune system and blood — to learn more about how the disease progresses and what treatments work best over time. **You may be eligible if...** - You have been diagnosed with GATA2 deficiency (a rare genetic mutation affecting your immune and blood cells) - You have a related condition such as a weakened immune system, bone marrow failure, lymphedema (swelling), or certain skin or hearing problems that may indicate GATA2 deficiency - You are willing to come in for regular monitoring visits - Family members of affected patients may also be eligible for genetic testing **You may NOT be eligible if...** - You are not able to travel to the study site for evaluation - You are unwilling to consent to genetic testing and long-term follow-up - You have another established diagnosis that fully explains all of your symptoms Talk to your doctor to see if this trial is right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01905826